Skip to main content
CTEV
NYSE Finance

Q3 EBITDA Beats and FY Revenue, EBITDA Outlook Tops Estimates

Tom Rudovsky · Reported by Reuters
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$22.71
Mkt Cap
$384.877M
52W Low
$11.5
52W High
$73.68
52W Position info
97% above low
Off High info
69% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

CTEV sits 97% above its 52-week low of $11.5.

Summary

Claritev posted Q3 adjusted EBITDA of $162 million, ahead of the $155.8 million IBES estimate, on revenue of $268.3 million, and guided FY revenue to $1,038-1,043 million versus $1,014 million expected. FY adjusted EBITDA guidance of $625-630 million also clears the $615.4 million consensus, and capex is set at $165-170 million. The company raised its 2026 outlook and sees preliminary 2027 revenue of $1.1 billion. The top-line beat and raised outlook are the story here, but the quarter still carried a $61.789 million net loss, a loss per share of $3.64 and $80.029 million pretax loss, so profitability remains pressured. This follows a Q2 that beat expectations but disclosed an unremediated material weakness and an ongoing DOJ civil probe, and comes after Ares-affiliated holders added roughly $1.68 million of stock in late October.

At the time of this announcement, CTEV was trading at $22.71 on NYSE in the Finance sector, with a market capitalization of approximately $384.9M. The 52-week trading range was $11.50 to $73.68. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

CTEV - Latest Insights

CTEV
Nov 09, 2026, 10:48 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $23.86
Real-time Price: $28.21 info
Change: +$4.35 (+18%) info
Market Cap: $481.68M info
CTEV
Nov 09, 2026, 6:05 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.71
Real-time Price: $28.21 info
Change: +$5.50 (+24%) info
Market Cap: $481.68M info
CTEV
Aug 07, 2026, 4:02 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $32.59
Real-time Price: $28.21 info
Change: -$4.38 (-13%) info
Market Cap: $481.68M info
CTEV
Aug 07, 2026, 6:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $26.84
Real-time Price: $28.21 info
Change: +$1.37 (+5%) info
Market Cap: $481.68M info
CTEV
Aug 07, 2026, 5:13 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $26.84
Real-time Price: $28.21 info
Change: +$1.37 (+5%) info
Market Cap: $481.68M info